Discussion
Most infants with Prader-Willi syndrome (PWS) experience sleep-disordered breathing and obstructive sleep apnea before ever starting growth hormone therapy, a small Belgian study shows. The findings challenge previous suggestions that growth hormone therapy, a standard treatment for PWS, is what primarily drives the risk of obstructive sleep apnea (OSA),…